Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
SoCal Biotech AtheroNova (AHRO) and its Subsidiary File for Chapter 11
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business
CALBIO15: Genomics Need to Bridge Gap Between Medicine and Science, Says Panel
CALBIO2015: "Health is the New Asset Class," Says Former Pfizer (PFE) Exec, With Daily Breakthroughs Coloring Investment
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics
Vertex (VRTX) Terminates Leases on Three Properties in Cambridge, Massachusetts
Baxter International (BAX) Starts Hiring in Anticipation of Planned Drug Spinout Baxalta
New Jersey Startup Celimmune Aims to Give New Life to Shelved Amgen (AMGN) Drug
Boston Scientific (BSX) Snags Endo International (ENDP)'s Urology Portfolio in Deal Worth $1.65 Billion
Ousted Sanofi (SAN.PA) CEO Lands Next Gig
See All News >
//-->